Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam · Delayed Price · Currency is VND 65,700
-800 (-1.20%)
At close: Jun 5, 2026
Ha Tay Pharmaceutical JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 53,657 | 71,772 | 85,056 | 95,211 | 67,946 |
Depreciation & Amortization | 24,143 | 20,481 | 17,078 | 17,448 | 16,651 |
Loss (Gain) From Sale of Assets | -20,385 | -14,478 | -4,608 | -9,923 | - |
Other Operating Activities | 1,913 | 5,087 | -1,352 | 2,653 | -14,450 |
Change in Accounts Receivable | 62,426 | 28,972 | 147,484 | -159,477 | 51,385 |
Change in Inventory | 16,499 | -149,027 | 81,720 | -120,922 | 33,804 |
Change in Accounts Payable | 88,468 | 67,274 | -55,823 | 133,037 | -182,898 |
Change in Other Net Operating Assets | -1,001 | -2,121 | 1,245 | 2,502 | 4,269 |
Operating Cash Flow | 225,719 | 27,959 | 270,799 | -39,471 | -23,293 |
Operating Cash Flow Growth | 707.32% | -89.68% | - | - | - |
Capital Expenditures | -48,759 | -143,132 | -366,523 | -246,553 | -60,524 |
Sale of Property, Plant & Equipment | 126.34 | 150 | 281 | 86.82 | 244.42 |
Investment in Securities | - | - | - | 297,000 | -350,000 |
Other Investing Activities | 14,103 | 7,215 | 3,627 | 26,265 | 106.17 |
Investing Cash Flow | -94,529 | -125,767 | -409,615 | 76,799 | -410,174 |
Long-Term Debt Issued | 648,788 | 746,915 | 782,402 | 774,504 | 741,472 |
Total Debt Issued | 648,788 | 746,915 | 782,402 | 774,504 | 741,472 |
Long-Term Debt Repaid | -785,911 | -780,429 | -615,546 | -727,089 | -656,225 |
Total Debt Repaid | -785,911 | -780,429 | -615,546 | -727,089 | -656,225 |
Net Debt Issued (Repaid) | -137,123 | -33,513 | 166,857 | 47,414 | 85,247 |
Issuance of Common Stock | - | - | 180,600 | - | 367,749 |
Common Dividends Paid | - | -80,194 | - | -51,288 | -20,359 |
Financing Cash Flow | -137,123 | -113,707 | 347,457 | -3,873 | 432,637 |
Foreign Exchange Rate Adjustments | -0.06 | -5.46 | 17.77 | 8.57 | 4.8 |
Net Cash Flow | -5,933 | -211,521 | 208,658 | 33,463 | -825.13 |
Free Cash Flow | 176,961 | -115,173 | -95,725 | -286,024 | -83,817 |
Free Cash Flow Margin | 7.37% | -5.52% | -4.79% | -15.57% | -5.21% |
Free Cash Flow Per Share | 2127.57 | -1271.59 | -1720.88 | -3516.64 | -1038.49 |
Cash Interest Paid | 13,107 | 13,417 | 20,100 | 14,350 | 13,953 |
Cash Income Tax Paid | 15,975 | 18,894 | 26,106 | 21,049 | 16,423 |
Levered Free Cash Flow | 164,407 | -68,973 | -134,881 | -308,353 | -114,140 |
Unlevered Free Cash Flow | 172,567 | -60,567 | -122,319 | -299,413 | -105,394 |
Change in Working Capital | 166,392 | -54,902 | 174,625 | -144,860 | -93,440 |